https://www.bloomberg.com/authors/ATSWyE0mPHI/ameet-sarpatwari RSS for Node Sun, 10 May 2026 13:48:44 GMT https://www.bloomberg.com/view/articles/2017-06-20/get-generic-drugs-to-market-faster https://www.bloomberg.com/view/articles/2017-06-20/get-generic-drugs-to-market-faster Tue, 20 Jun 2017 11:00:15 GMT Ranbaxy Laboratories Ltd.'s Atorvastatin Calcium Tablets IP Storvas 10 tablets are arranged for a photograph in Mumbai, India, on Thursday, Feb. 20, 2014. The U.S. is increasing scrutiny of generic drugs made in India, and in the past nine months banned imports from four plants belonging to Ranbaxy Laboratories Ltd. and Wockhardt Ltd. Photographer: Dhiraj Singh/Bloomberg via Getty Images